Derma Sciences Cmn (DSCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -38,108 | -39,772 | -23,964 | -12,070 | -4,340 |
| Depreciation Amortization | 3,911 | 3,943 | 3,721 | 3,296 | 2,637 |
| Income taxes - deferred | -2,726 | 15 | 132 | -2,507 | 83 |
| Accounts receivable | 324 | -1,438 | -267 | -330 | -814 |
| Accounts payable and accrued liabilities | -1,643 | 680 | 574 | -400 | 237 |
| Other Working Capital | -3,959 | 3,684 | -2,500 | -3,374 | -1,028 |
| Other Operating Activity | 6,777 | 6,880 | 5,102 | 3,482 | 3,474 |
| Operating Cash Flow | $-35,423 | $-26,007 | $-17,202 | $-11,904 | $250 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 30,992 | -41,006 | -19,246 | 1,246 | -5,474 |
| PPE Investments | -1,811 | -1,733 | -696 | -779 | -979 |
| Net Acquisitions | N/A | N/A | N/A | -14,358 | N/A |
| Purchase Sale Intangibles | N/A | -1,125 | -350 | -2,300 | -1,000 |
| Other Investing Activity | 0 | -1,125 | -350 | -2,300 | -1,000 |
| Investing Cash Flow | $29,181 | $-43,863 | $-20,292 | $-16,191 | $-7,453 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | -3,076 |
| Debt Repayment | N/A | N/A | N/A | N/A | -6 |
| Common Stock Issued | 1,993 | 82,887 | 2,817 | 52,687 | 26,975 |
| Other Financing Activity | -169 | -300 | -228 | -81 | 0 |
| Financing Cash Flow | $1,824 | $82,587 | $2,589 | $52,606 | $23,894 |
| Exchange Rate Effect | 836 | 179 | -210 | -5 | 16 |
| Beginning Cash Position | 19,397 | 6,502 | 41,617 | 17,110 | 404 |
| End Cash Position | 15,814 | 19,397 | 6,502 | 41,617 | 17,110 |
| Net Cash Flow | $-3,583 | $12,895 | $-35,115 | $24,506 | $16,706 |
| Free Cash Flow | |||||
| Operating Cash Flow | -35,423 | -26,007 | -17,202 | -11,904 | 250 |
| Capital Expenditure | -1,811 | -1,733 | -696 | -826 | -979 |
| Free Cash Flow | -37,234 | -27,740 | -17,898 | -12,731 | -729 |